- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,724,358
- Total 13F shares
- 95,536,900
- Share change
- +4,444,301
- Total reported value
- $3,516,647,768
- Put/Call ratio
- 46%
- Price per share
- $36.81
- Number of holders
- 233
- Value change
- +$153,742,395
- Number of buys
- 111
- Number of sells
- 115
Quarterly Holders Quick Answers
What is CUSIP 23282W605?
CUSIP 23282W605 identifies CYTK - CYTOKINETICS INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23282W605:
Top shareholders of CYTK - CYTOKINETICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
12,950,964
|
$590,305,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
10%
|
12,540,549
|
$571,598,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.6%
|
6,989,719
|
$318,592,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
3,985,227
|
$181,647,000 | — | 31 Dec 2021 | |
| Polar Capital Holdings Plc |
13F
|
Company |
3%
|
3,671,969
|
$167,368,000 | — | 31 Dec 2021 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
2.1%
|
2,604,797
|
$118,727,000 | — | 31 Dec 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.1%
|
2,561,182
|
$116,739,000 | — | 31 Dec 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
2%
|
2,465,016
|
$112,355,000 | — | 31 Dec 2021 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,327,112
|
$106,070,000 | — | 31 Dec 2021 | |
| WASATCH ADVISORS LP |
13F
|
Company |
1.8%
|
2,183,250
|
$99,513,000 | — | 31 Dec 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
2,170,342
|
$98,924,000 | — | 31 Dec 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.7%
|
2,100,000
|
$95,718,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,428,622
|
$65,116,000 | — | 31 Dec 2021 | |
| Logos Global Management LP |
13F
|
Company |
1.1%
|
1,325,000
|
$60,394,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.91%
|
1,123,072
|
$51,190,000 | — | 31 Dec 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.84%
|
1,039,073
|
$47,361,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.82%
|
1,009,345
|
$46,007,000 | — | 31 Dec 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.81%
|
1,000,000
|
$45,580,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.72%
|
885,454
|
$40,359,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.71%
|
881,169
|
$40,165,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.7%
|
871,658
|
$39,730,000 | — | 31 Dec 2021 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.68%
|
840,601
|
$38,315,000 | — | 31 Dec 2021 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.67%
|
833,068
|
$37,971,000 | — | 31 Dec 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.65%
|
809,000
|
$36,874,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.63%
|
779,100
|
$35,511,000 | — | 31 Dec 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.61%
|
759,669
|
$34,625,000 | — | 31 Dec 2021 | |
| Commodore Capital LP |
13F
|
Company |
0.57%
|
704,537
|
$32,113,000 | — | 31 Dec 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.57%
|
700,000
|
$31,906,000 | — | 31 Dec 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.55%
|
677,116
|
$30,863,000 | — | 31 Dec 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.53%
|
660,815
|
$30,120,000 | — | 31 Dec 2021 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.5%
|
619,664
|
$28,244,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.48%
|
588,741
|
$26,835,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.47%
|
584,666
|
$26,649,000 | — | 31 Dec 2021 | |
| Opaleye Management Inc. |
13F
|
Company |
0.47%
|
580,000
|
$26,436,000 | — | 31 Dec 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.45%
|
559,582
|
$25,506,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
558,704
|
$25,466,000 | — | 31 Dec 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.41%
|
513,344
|
$23,398,000 | — | 31 Dec 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.38%
|
464,366
|
$21,166,000 | — | 31 Dec 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.34%
|
416,497
|
$18,983,000 | — | 31 Dec 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.29%
|
356,929
|
$16,269,000 | — | 31 Dec 2021 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.28%
|
350,000
|
$15,953,000 | — | 31 Dec 2021 | |
| Bain Capital Public Equity Management II, LLC |
13F
|
Company |
0.28%
|
341,272
|
$15,555,000 | — | 31 Dec 2021 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.26%
|
325,000
|
$14,814,000 | — | 31 Dec 2021 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.25%
|
315,192
|
$14,366,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.24%
|
294,733
|
$13,433,000 | — | 31 Dec 2021 | |
| CM Management, LLC |
13F
|
Company |
0.22%
|
275,000
|
$12,535,000 | — | 31 Dec 2021 | |
| David Cragg |
3/4/5
|
Chief HR & Admin Officer |
—
mixed-class rows
|
203,233
mixed-class rows
|
$12,476,231 | — | 07 Mar 2022 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.22%
|
268,586
|
$12,242,000 | — | 31 Dec 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.2%
|
245,198
|
$11,176,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.2%
|
244,373
|
$11,139,000 | — | 31 Dec 2021 |
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q1 2022
As of 31 Mar 2022,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,536,900 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, Polar Capital Holdings Plc, RTW INVESTMENTS, LP, PICTET ASSET MANAGEMENT SA, PFM Health Sciences, LP, LORD, ABBETT & CO. LLC, and BOXER CAPITAL, LLC.
This page lists
234
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
244
Q1 2022 holders
233
Holder diff
-11
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.